Preferred Label : Peroxisome biogenesis disorder 8b;
Symbol : PBD8B;
CISMeF acronym : PBD8B;
Type : Phenotype, molecular basis known;
Description : The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum
disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum
(ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the
NALD and IRD presentation is variable and may include developmental delay, hypotonia,
liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment.
Children with the NALD presentation may reach their teens, and those with the IRD
presentation may reach adulthood (summary by Waterham and Ebberink, 2012). For a complete
phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD),
see 601539. Individuals with mutations in the PEX16 gene have cells of complementation
group 9 (CG9, equivalent to CGD). For information on the history of PBD complementation
groups, see 214100.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the peroxisome biogenesis factor 16 gene (PEX16, 603360.0003);
Laboratory abnormalities : Elevated C27 bile acid intermediates; Elevated pristanic acid; Normal plasmalogen levels in erythrocytes; Elevated phytanic acid; Markedly enlarged, incompetent peroxisomes in fibroblasts; Normal immunoblot profile; Docosahexaenoic acid (DHA) deficiency; Reduced numbers of peroxisomes in fibroblasts; Elevated very long chain fatty acids (VLCFA);
Prefixed ID : #614877;
Origin ID : 614877;
UMLS CUI : C3553960;
Automatic exact mappings (from CISMeF team)
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)